Department of Medicinal Chemistry and Pharmaceutical Sciences Research Center, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
Eur J Med Chem. 2013 Oct;68:185-91. doi: 10.1016/j.ejmech.2013.07.032. Epub 2013 Aug 11.
Novel Mannich bases of 7-piperazinylquinolones with kojic acid and chlorokojic acid were designed as new quinolone antibacterials. All compounds showed significant in vitro antibacterial activity against both Gram-positive and Gram-negative bacteria. Particularly, chlorokojic derivative 2b was the most potent compound against Staphylococcus aureus and Pseudomonas aeruginosa (MIC values≤0.19 μg/mL). Its activity was 4-8 times more than that of standard drug norfloxacin. The molecular docking study of compound 2b further supported the molecular basis of the designed compounds.
新型曼尼希碱 7-哌嗪基喹诺酮与曲酸和氯曲酸被设计为新型喹诺酮类抗菌药物。所有化合物均表现出对革兰氏阳性菌和革兰氏阴性菌的显著体外抗菌活性。特别是氯曲酸衍生物 2b 对金黄色葡萄球菌和铜绿假单胞菌(MIC 值≤0.19 μg/mL)具有最强的活性。其活性是标准药物诺氟沙星的 4-8 倍。化合物 2b 的分子对接研究进一步支持了设计化合物的分子基础。